| Followers | 19 |
| Posts | 6605 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Sunday, June 28, 2020 12:53:46 PM
https://www.sapling.com/12099380/calculate-cost-basis-after-How to Calculate Cost Basis After a Spin-Off
By John Csiszar Updated March 28, 2017
Cost basis is the total amount that you paid for an investment, such as a stock. A spin-off occurs when a company divides itself into two or more pieces. If you own stock in a company that has a spin-off, the cost basis you have in the original company is divided amongst the resulting divisions. To calculate your cost basis in the now-separate entities, you must allocate your original cost basis in the same proportion that the company assigns to the resultant companies.
Step 1
Locate your cost basis for the original company. This is the total amount you paid for the original stock, including any fees or commissions charged by your financial services firm.
Step 2
Record the closing prices of the two (or more) stocks as of the first day the spin-off traded as an individual company.
Step 3
Add the closing prices of the mother company and the spin-off.
Step 4
Calculate the proportion of total combined share price represented by each individual company. For example, if the mother company stock closes at a price of $60 and the spin-off company closes at a price of $40, the combined share price is $100. Of this amount, the mother company comprises 60 percent while the spin-off company represents 40 percent.
Step 5
Multiply the individual stock proportions by your original cost basis. If your original cost basis was $120 per share and the spin-off receives a 40 percent cost basis allocation, the net cost basis for the spin-off will be $48. The remaining $72 in cost basis is allocated to the original company.
Tip
In most cases, the original company will provide shareholders with an allocation factor for the cost basis in the new spin-off.
A spin-off is usually a non-taxable event.
By John Csiszar Updated March 28, 2017
Cost basis is the total amount that you paid for an investment, such as a stock. A spin-off occurs when a company divides itself into two or more pieces. If you own stock in a company that has a spin-off, the cost basis you have in the original company is divided amongst the resulting divisions. To calculate your cost basis in the now-separate entities, you must allocate your original cost basis in the same proportion that the company assigns to the resultant companies.
Step 1
Locate your cost basis for the original company. This is the total amount you paid for the original stock, including any fees or commissions charged by your financial services firm.
Step 2
Record the closing prices of the two (or more) stocks as of the first day the spin-off traded as an individual company.
Step 3
Add the closing prices of the mother company and the spin-off.
Step 4
Calculate the proportion of total combined share price represented by each individual company. For example, if the mother company stock closes at a price of $60 and the spin-off company closes at a price of $40, the combined share price is $100. Of this amount, the mother company comprises 60 percent while the spin-off company represents 40 percent.
Step 5
Multiply the individual stock proportions by your original cost basis. If your original cost basis was $120 per share and the spin-off receives a 40 percent cost basis allocation, the net cost basis for the spin-off will be $48. The remaining $72 in cost basis is allocated to the original company.
Tip
In most cases, the original company will provide shareholders with an allocation factor for the cost basis in the new spin-off.
A spin-off is usually a non-taxable event.
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
- CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
- CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
